Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis

Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis

With the rising incidence of hepatocellular carcinoma (HCC) from non-alcoholic steatohepatitis (NASH), identifying new metabolic readouts that function in metabolic pathway perpetuation is still a demand. The study aimed to compare the metabolic signature between NASH and NASH-HCC patients to explor...

Full description

Bibliographic Details
Main Authors: Eman A. Ahmed, Marwa O. El-Derany, Ali Mostafa Anwar, Essa M. Saied, Sameh Magdeldin
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
non-alcoholic steatohepatitis
hepatocellular carcinoma
metabolomic
lipidomic
pathway reprogramming
Online Access:https://www.mdpi.com/1422-0067/24/1/210

Internet

https://www.mdpi.com/1422-0067/24/1/210

Similar Items